Mrv1909 12161923472D 16 16 0 0 0 0 999 V2000 2.4903 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7758 0.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.0819 0.0000 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 0.3469 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0614 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3675 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7964 0.4125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.0819 -0.8249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7964 -1.2374 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.2048 0.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.3675 -1.2374 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.4903 1.2375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -3.2048 -0.1708 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.7964 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.6214 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.6214 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12 1 2 0 0 0 0 10 1 1 0 0 0 0 1 2 1 0 0 0 0 3 8 1 1 0 0 0 2 5 1 0 0 0 0 4 5 1 0 0 0 0 6 4 1 0 0 0 0 3 6 1 0 0 0 0 3 7 1 0 0 0 0 7 14 1 0 0 0 0 15 7 1 0 0 0 0 11 8 2 0 0 0 0 9 8 1 0 0 0 0 13 15 2 0 0 0 0 16 14 1 0 0 0 0 16 15 1 0 0 0 0 M END > DB02475 > drugbank > NC(=N)NCCC[C@H](N1CCC1=O)C(O)=O > InChI=1S/C9H16N4O3/c10-9(11)12-4-1-2-6(8(15)16)13-5-3-7(13)14/h6H,1-5H2,(H,15,16)(H4,10,11,12)/t6-/m0/s1 > UYADDEKIZFRINK-LURJTMIESA-N > C9H16N4O3 > 228.2483 > 228.122240398 > 6 > 32 > 0.001155102301804754 > 23.314551064736584 > 1 > 4 > 0 > 0 > (2S)-5-carbamimidamido-2-(2-oxoazetidin-1-yl)pentanoic acid > -1.44 > -3.1530504483804926 > -2.22 > 0 > 0 > 1 > 0 > 3.512548836735964 > 12.228067371133642 > 119.50999999999999 > 66.40390000000001 > 6 > 1 > 1.38e+00 g/l > cysteine hcl > 0 > DB02475 > EXPT02527 > experimental > Deoxyamidinoproclavaminic acid > Deoxyamidinoproclavaminate; Deoxyguanidinoproclavaminate; Deoxyguanidinoproclavaminic acid $$$$